首页|期刊导航|天津中医药大学学报|BN大鼠和RBL-2H3细胞体内外实验评价丹红注射液致敏性风险

BN大鼠和RBL-2H3细胞体内外实验评价丹红注射液致敏性风险OA

Evaluation of the sensitization risk of Danhong Injection based on in vivo and in vitro experiments using BN rats and RBL-2H3 cells

中文摘要英文摘要

[目的]研究通过体内外实验评估丹红注射液的致敏性风险.[方法]丹红注射液与临床常用溶媒配伍后进行理化性质相关检测.体外实验中,大鼠嗜碱性粒细胞白血病细胞(RBL-2H3)给药分组设置为阴性对照组、阳性对照组(C48/80组)、丹红注射液(20、30、50 μL/mL)组分别检测细胞活力、甲苯胺蓝染色、脱颗粒标志物[免疫球蛋白E(IgE)、组胺(His)、β氨基已糖苷酶(β-Hex)、类胰蛋白酶(TPS)].采用BN大鼠致敏模型(阴性对照组、阳性对照组、丹红氯化钠组、丹红葡萄糖组),通过双次激发实验观察过敏反应,取血及肺组织进行病理分析.[结果]丹红注射液与溶媒配伍后理化性质稳定;高剂量丹红注射液(50 μL/mL)(P<0.05)显著提升RBL-2H3细胞His释放量.体内实验未发现BN大鼠出现显著过敏反应.[结论]丹红注射液在常规剂量下未表现显著致敏性.

[Objective]This study aimed to evaluate the sensitization risk of Danhong Injection through in vivo and in vitro experiments.[Methods]The physicochemical properties of Danhong Injection were tested after compatibility with commonly used clinical solvents.For the in vitro experiment,RBL-2H3 cells were allocated to a negative control group,a positive control group(C48/80),and Danhong Injection groups(20,30 and 50 μL/mL).Cell viability,toluidine blue staining,and the levels of degranulation markers(immunoglobulin E(IgE),histamine(His),β-hexosaminidase(β-Hex),and tryptase(TPS))were assessed.A BN rat sensitization model was established,including normal saline control,ovalbumin positive control,Danhong Injection-sodium chloride injection compatibility,and Danhong Injection-glucose injection compatibility groups.Allergic reactions were observed following a double-challenge protocol.Blood and lung tissues were collected for histopathological analysis.[Results]Danhong Injection exhibited stable physicochemical properties after compatibility.In RBL-2H3 cells,the high dose(50 μL/mL)of Danhong Injection significantly increased histamine release(P<0.05).However,no significant allergic reactions were observed in BN rats in vivo.[Conclusion]Danhong Injection did not demonstrate significant sensitization risk at conventional clinical doses.

戎薪夷;王益民;孙海丽;吕春晓;黄宇虹

天津中医药大学第二附属医院,天津 300350||天津中医药大学,天津 301617山东步长制药股份有限公司,菏泽 274000北京卓越未来国际医药科技发展有限公司,北京 100176天津中医药大学第二附属医院,天津 300350天津中医药大学第二附属医院,天津 300350

医药卫生

丹红注射液类过敏BN大鼠脱颗粒

Danhong Injectionpseudo-allergyBN ratdegranulation

《天津中医药大学学报》 2026 (3)

308-316,9

科技部重大新药创制项目(2015ZX09101043-009).

10.11656/j.issn.1673-9043.2026.03.08

评论